An acute, epitope-specific modification in the dopamine transporter associated with methamphetamine-induced neurotoxicity

Synapse
Ashley N Fricks-GleasonKristen A Keefe

Abstract

Preclinical studies demonstrate that repeated, high-dose methamphetamine administrations rapidly decrease plasmalemmal dopamine uptake, which may contribute to aberrant dopamine accumulation, reactive species generation, and long-term dopaminergic deficits. The present study extends these findings by demonstrating a heretofore unreported, epitope-specific modification in the dopamine transporter caused by a methamphetamine regimen that induces these deficits. Specifically, repeated, high-dose methamphetamine injections (4 × 10 mg/kg/injection, 2-h intervals) rapidly decreased immunohistochemical detection of striatal dopamine transporter as assessed 1 h after the final methamphetamine exposure. In contrast, neither a single high dose (1 × 10 mg/kg) nor repeated injections of a lower dose (4 × 2 mg/kg/injection) induced this change. The high-dose regimen-induced alteration was only detected using antibodies directed against the N-terminus. Immunohistochemical staining using antibodies directed against the C-terminus did not reveal any changes. The high-dose regimen also did not alter dopamine transporter expression as assessed using [(125) I]RTI-55 autoradiography. These data suggest that the repeated, high-dose methamphetamine ...Continue Reading

References

Apr 4, 1997·European Journal of Pharmacology·A E FleckensteinG R Hanson
Oct 21, 1998·Methods in Enzymology·G W MillerA I Levey
Dec 29, 1998·European Journal of Pharmacology·J M KokoshkaA E Fleckenstein
May 24, 2000·Proceedings of the National Academy of Sciences of the United States of America·C SaundersA Galli
Mar 7, 2001·The American Journal of Psychiatry·N D VolkowE N Miller
May 8, 2002·The Journal of Biological Chemistry·James D FosterRoxanne A Vaughan
Dec 3, 2003·Brain : a Journal of Neurology·Anna MoszczynskaStephen J Kish
Apr 2, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Anthony J BaucumAnnette E Fleckenstein
Apr 6, 2004·The Journal of Pharmacology and Experimental Therapeutics·Roxanne A Vaughan
Oct 27, 2004·Pharmacology & Therapeutics·Haley E Melikian
Aug 20, 2005·The Journal of Biological Chemistry·Manuel MirandaAlexander Sorkin
Oct 11, 2005·Neuropharmacology·L'aurelle A JohnsonMargaret E Gnegy
Jan 4, 2006·Archives of General Psychiatry·Yoshimoto SekineNorio Mori
May 26, 2006·Handbook of Experimental Pharmacology·J D FosterR A Vaughan
Aug 4, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Tatiana SorkinaAlexander Sorkin
Apr 11, 2007·Journal of Neurochemistry·B R HooverN R Zahniser
May 30, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Yoshimoto SekineJean L Cadet
Jul 12, 2008·Molecular Pharmacology·Francesca BindaAurelio Galli
Oct 9, 2008·Psychopharmacology·Stephen J KishJunchao Tong
Dec 3, 2008·The Journal of Biological Chemistry·J Shawn GoodwinHabibeh Khoshbouei
Dec 23, 2008·The Journal of Pharmacology and Experimental Therapeutics·Rong ChenMargaret E Gnegy
Jan 17, 2009·Biochemistry·Balachandra K GorentlaRoxanne A Vaughan
Jan 30, 2010·Legal Medicine·Osamu KitamuraShin-ichi Kubo
Mar 6, 2010·Annals of the New York Academy of Sciences·Kyle C Schmitt, Maarten E A Reith
Aug 26, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Russell C CallaghanStephen J Kish
Jul 30, 2011·Biochemistry·Jonathan J Sager, Gonzalo E Torres
Jun 20, 2012·Trends in Neurosciences·John F Marshall, Steven J O'Dell
Dec 12, 2012·The Journal of Pharmacology and Experimental Therapeutics·Danielle M FriendAshley N Fricks-Gleason
Sep 18, 2015·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Ethan R BlockAlexander Sorkin

❮ Previous
Next ❯

Citations

Feb 10, 2021·Harvard Review of Psychiatry·Alan A Baumeister
Jul 22, 2021·Archives of Pharmacal Research·Eun-Joo ShinHyoung-Chun Kim

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Journal of Pharmacology and Experimental Therapeutics
Kamisha L Johnson-DavisD G Wilkins
The Journal of Pharmacology and Experimental Therapeutics
Kristi S RauA E Fleckenstein
© 2022 Meta ULC. All rights reserved